Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 60 of 1,261
  1. US 12234294

    Pharmaceutical composition of a humanized anti-CD40 antibody

    Kiniksa Pharmaceuticals, GmbH · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  2. US 12234277

    Hydrophobic interaction chromatography for viral clearance

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  3. US 12234288

    Immunogenic arginase 2 polypeptides

    IO Biotech ApS · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  4. US 12234302

    Chitosan derivatives and methods for preparing the same

    PRIMEX EHF · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  5. US 12234460

    Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  6. US 12234461

    Targeted non-viral DNA insertions

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  7. US 12234474

    Method to prevent the myelin abnormalites associated with arginase deficiency

    The Regents of the University of California · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  8. US 12233087

    Palladium hyaluronic acid particles and methods of managing cancer or angiogenic conditions

    The United States Government represented byt The United States Department of Veterans Affairs · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  9. US 12233080

    Lipotechoic acid for immune modulation

    Northwestern University · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  10. US 12233103

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  11. US 12233129

    Methods and compositions for the treatment of cancer

    SOUTH DAKOTA BOARD OF REGENTS · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  12. US 12233135

    Therapeutic constructs for treating cancer

    PRECISION MOLECULAR INC. · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  13. US 12234236

    GLP-1R agonist and therapeutic method thereof

    Ascletis Pharma (China) Co., Limited · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  14. US 12234295

    Chimeric transmembrane protein comprising antibody dimerization domains and a type I cytokine receptor endodomain, encoding nucleic acids thereof and methods of use thereof

    AUTOLUS LIMITED · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  15. US 12234300

    Conjugated hepcidin mimetics

    Protagonist Therapeutics, Inc. · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  16. US 2025059280

    METHODS OF TREATING HUMAN IMMUNODEFICIENCY VIRUS (HIV) DISEASE

    ABBVIE INC [US] · Granted Feb 20, 2025 · Expires Feb 15, 2045

    granted
  17. WO 2025038863

    DÉRIVÉS D'INDOLE ET DE PYRROLOYPYRIDINE UTILISÉS EN TANT QUE MODULATEURS DE GPR17

    BIOGEN MA INC [US] · Granted Feb 20, 2025 · Expires Feb 15, 2045

    granted
  18. US 2025057837

    Methods for Treating HCV

    ABBVIE INC [US] · Granted Feb 20, 2025 · Expires Feb 15, 2045

    granted
  19. US 12227740

    CBLB endonuclease variants, compositions, and methods of use

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  20. US 12226456

    Nasal powder formulation for treatment of hypoglycemia

    Amphastar Pharmaceuticals, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  21. US 12227580

    Antigen binding molecules that bind LIGHT

    CENTESSA PHARMACEUTICALS (UK) LIMITED · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  22. US 12227581

    Anti-BCMA single domain antibodies and application thereof

    SHENZHEN PREGENE BIOPHARMA CO., LTD. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  23. US 12226474

    Methods and compositions for treating infections

    Decoy Therapeutics Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  24. US 12226444

    Compositions comprising peptides comprising variant kinesin light chain 1 and cell-penetrating peptides

    Northwestern University · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.